Cargando…
An autophagy-dependent anticancer immune response determines the efficacy of melanoma chemotherapy
There is ample experimental and clinical evidence that chemotherapies are more efficient if they succeed in (re)activating immune surveillance, hence triggering a long-term immune response against residual tumor cells. Most of the preclinical evidence supporting this notion has been obtained with tr...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292732/ https://www.ncbi.nlm.nih.gov/pubmed/25610726 http://dx.doi.org/10.4161/21624011.2014.944047 |